Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) EBT Margin: 2016-2024

Historic EBT Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -0.58%.

  • Organogenesis Holdings' EBT Margin rose 897.00% to 14.03% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.33%, marking a year-over-year increase of 193.00%. This contributed to the annual value of -0.58% for FY2024, which is 298.00% down from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' EBT Margin is -0.58%, which was down 124.27% from 2.40% recorded in FY2023.
  • Organogenesis Holdings' 5-year EBT Margin high stood at 13.50% for FY2021, and its period low was -0.58% during FY2024.
  • In the last 3 years, Organogenesis Holdings' EBT Margin had a median value of 2.40% in 2023 and averaged 2.11%.
  • Per our database at Business Quant, Organogenesis Holdings' EBT Margin spiked by 2,003bps in 2020 and then slumped by 900bps in 2022.
  • Over the past 5 years, Organogenesis Holdings' EBT Margin (Yearly) stood at 5.25% in 2020, then skyrocketed by 825bps to 13.50% in 2021, then plummeted by 900bps to 4.50% in 2022, then tumbled by 210bps to 2.40% in 2023, then slumped by 298bps to -0.58% in 2024.